Drug Shortage Report for JAMP-MONTELUKAST

Last updated on 2022-07-20 History
Report ID 154922
Drug Identification Number 02442361
Brand name JAMP-MONTELUKAST
Common or Proper name Montelukast chewable tablets
Company Name JAMP PHARMA CORPORATION
Market Status CANCELLED POST MARKET
Active Ingredient(s) MONTELUKAST
Strength(s) 5MG
Dosage form(s) TABLET (CHEWABLE)
Route of administration ORAL ORAL
Packaging size 30 (blister pack)
ATC code R03DC
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-02-09
Actual start date
Estimated end date 2022-07-29
Actual end date 2022-07-19
Shortage status Resolved
Updated date 2022-07-20
Company comments This report was created in double
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2022-07-20 English Compare
v10 2022-07-19 French Compare
v9 2022-07-19 English Compare
v8 2022-07-19 French Compare
v7 2022-07-19 English Compare
v6 2022-05-17 French Compare
v5 2022-05-17 English Compare
v4 2022-03-08 French Compare
v3 2022-03-08 English Compare
v2 2022-02-14 French Compare
v1 2022-02-14 English Compare

Showing 1 to 11 of 11